Atrial fibrillation (AF) greatly increases the risk ofstroke. Long-term oral therapy with warfarin reducesthe risk of AF-related stroke by 62%, and nationalguidelines now call for warfarin therapy in ...

Chronic warfarin anticoagulation is commonly used to prevent thromboembolism in patients with atrial fibrillation or venous thromboembolism, and in the management of patients with mechanical heart ...

OpenEvidence and the Anticoagulation Forum (AC Forum) today announced a strategic partnership to provide antithrombotic guidance and tools that support decision-making in clinical practice. By ...

Objective: To provide recommendations, policies, and procedures pertaining to the provision of optimized anticoagulation therapy designed to achieve desired clinical endpoints while minimizing the ...

Conference session discussed anticoagulation care, stroke prevention, and management of thromboembolic disorders. Managed care pharmacists involved in the care for patients at risk for thromboembolic ...

At what platelet count can I safely initiate long-term anticoagulation with warfarin (Coumadin) in cancer patients with thrombocytopenia and persistent atrial fibrillation (AF)?—EDGAR C. SALIRE, NP-C, ...

The AustralaSian COVID-19 Trial (ASCOT) has pinpointed the most efficient level of blood thinning treatment needed for patients hospitalized with COVID-19, in a study published in the New England ...

Discontinuing oral anticoagulation (OAC) therapy resulted in a lower risk of a composite of stroke, systemic embolism or major bleeding than continuing OAC therapy in patients who had successful ...

For decades, paediatric anticoagulation has been guided more by extrapolation than by evidence. Treatments for venous thromboembolism in children have largely mirrored adult practice, despite ...

Three-arm randomized trial of sodium alginate, orally administered mucoprotective agent, for preventing radiation esophagitis in pts with locally advanced non-small-cell lung cancer (LA-NSCLC) ...